Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TGM2: a cell surface marker in esophageal adenocarcinomas.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Jun 2014

Leicht Deborah T, Kausar Tasneem, Wang Zhuwen, Ferrer-Torres Daysha, Wang Thomas D, Thomas Dafydd G, Lin Jules, Chang Andrew C, Lin Lin, Beer David G

Abstract excerpt

INTRODUCTION: Esophageal adenocarcinomas (EAC) are aggressive cancers that are increasing in incidence and associated with a poor prognosis. The identification of highly expressed genes in EAC relative to metaplastic Barrett's esophagus (BE) may provide new targets for novel early cancer detectio...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Barrett Esophagus
Share to Esophageal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Knockdown Techniques

Share to GTP-Binding Proteins

Share to Neoadjuvant Therapy

Share to Protein Glutamine gamma Glutamyltransferase 2

Share to Tissue Array Analysis

Share to Transglutaminases

Source

Open in PubMed Open full text

Identifiers

PMID: 24828664
DOI: 10.1097/JTO.0000000000000229
PMCID: PMC4170218

Genes

TGM2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24828664-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TGM2: a cell surface marker in esophageal adenocarcinomas.PMID 24828664Read ↗

Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancerSemantic proximity Read ↗

Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53Semantic proximity Read ↗

Tissue transglutaminase: a new target to reverse cancer drug resistanceSemantic proximity Read ↗

Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21‐mediated ubiquitination/degradation of STAT1 in a GTP binding‐dependent modalitySemantic proximity Read ↗

Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy targetSemantic proximity Read ↗

Epigenetic alterations of TP53INP1 by EHMT2 regulate the cell cycle in gastric cancerSemantic proximity Read ↗

The Role of Transglutaminase 2 in Cancer: An UpdateSemantic proximity Read ↗

Utility of molecular genetic signatures in the delineation of gastric neoplasia.Semantic proximity Read ↗

Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.Semantic proximity Read ↗

Transglutaminase 2 Regulates Self-renewal and Stem Cell Marker of Human Colorectal Cancer Stem CellsSemantic proximity Read ↗

Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma.Semantic proximity Read ↗

DSG2-Directed CAR-T Cells Safely and Universally Eliminate Solid TumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.